- Home
- MSB vs SOPH Comparison
MSB vs SOPH Comparison
Compare MSB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSB | SOPH |
|---|---|---|
| Founded | 1961 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 367.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MSB | SOPH |
|---|---|---|
| Price | $33.48 | $4.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 52.4K | ★ 361.7K |
| Earning Date | 04-24-2026 | 03-03-2026 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.31 | N/A |
| Revenue | $20,785,076.00 | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.48 |
| Revenue Next Year | N/A | $16.25 |
| P/E Ratio | $25.91 | ★ N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $22.55 | $2.58 |
| 52 Week High | $42.38 | $5.70 |
Technical Indicators
Market Signals| Indicator | MSB | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 42.86 |
| Support Level | $33.05 | $4.61 |
| Resistance Level | $36.21 | $4.85 |
| Average True Range (ATR) | 1.72 | 0.29 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 26.01 | 15.69 |
Price Performance
Historical ComparisonAbout MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.